{"retracted":false,"update":{"timestamp":1479168000000,"doi":"10.1016/j.ijcard.2016.08.333","type":"erratum"},"doi":"10.1016/j.ijcard.2015.08.080","journal":"International Journal of Cardiology","publisher":"Elsevier BV","title":"Corrigendum to “FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion” [Int. J. Cardiol. 202 (2016) 52–58]"}
